Acticor Biotech
ALACT | PA
Overview
Corporate Details
- ISIN(s):
- FR0012519668 (+1 more)
- LEI:
- 969500K433EK1G89EV95
- Country:
- France
- Address:
- 82 AVENUE DU MAINE, 75014 PARIS
- Website:
- https://www.acticor-biotech.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the world and the leading cause of death among women. It is also the first cause of adult acquired disabilities resulting from the neurological damages sustained by 75% of the survivors.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-01-06 08:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 171.0 KB | |
| 2025-01-06 08:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 169.3 KB | |
| 2024-12-19 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 205.7 KB | |
| 2024-12-19 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 214.6 KB | |
| 2024-12-10 18:00 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 202.1 KB | |
| 2024-12-10 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 214.1 KB | |
| 2024-11-06 08:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 177.1 KB | |
| 2024-11-06 08:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 179.2 KB | |
| 2024-11-04 11:46 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 322.8 KB | |
| 2024-11-04 11:46 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 311.2 KB | |
| 2024-10-31 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 400.7 KB | |
| 2024-10-31 17:45 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 464.4 KB | |
| 2024-10-16 17:45 |
Regulatory News Service
Inside Information / Other news releases
|
English | 289.1 KB | |
| 2024-10-16 17:45 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 223.1 KB | |
| 2024-10-14 08:00 |
Board/Management Change
Informations privilégiées / Autres communiqués
|
French | 275.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Advicenne | France | ALDVI | |
|
Aelis Farma | France | AELIS | |
|
Aker BioMarine | Norway | AKBM | |
|
ALK-Abelló | Denmark | ALK | |
|
Alligator Bioscience | Sweden | ATORX | |
|
Alvotech Holdings S.A | Luxembourg | ALVO | |
|
AlzeCure Pharma | Sweden | ALZCUR | |
|
Alzinova AB | Sweden | ALZ | |
| Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS | Türkiye | ANGEN | ||
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR |